MARKETS
Earnings

Neuraxis Q2 EPS $(0.19) Beats $(0.32) Estimate, Sales $1.929M Miss $2.000M Estimate

Aug 11, 2026 · 07:11 AM ET· updated 1h ago

Neuraxis (AMEX:NRXS) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.32) by 40.63 percent. This is a 13.64 percent increase over losses of $(0.22) per share from the same

Share
Why It Matters

Neuraxis lost less money than people expected, which is good—but the company made less money from selling things than hoped for, which is concerning. When a company loses less money it's a small positive sign, but missing sales targets hints the business might be struggling to grow.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.